Selvita

Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.

Selvita's mission is to enable its partners to discover, develop and deliver innovative therapies for patients across the world.

Selvita’s vision is to become the most respected CRO in the life science and pharmaceutical industries.

Selvita has been consistently listed by Deloitte among the 50 fastest growing technology companies in Central Europe and was awarded with ‘Exporter of the Future’ title by ‘Polish Agency for Enterprise Development’ in the Business Gazelle ranking. Selvita was also awarded the Forbes Diamonds and Employer of the Future in 2020.